Siemens Healthineers AG Q4 2025 Earnings Recap

SHL.DE Q4 2025 November 5, 2025

Siemens Healthineers finished fiscal year 2025 with solid growth, exceeding guidance driven by strong global demand, while maintaining a robust book-to-bill ratio.

Earnings Per Share Miss

$0.69 vs $0.70 est.

-1.1% surprise

Revenue Miss

6322000000 vs 6594870404 est.

-4.1% surprise

Market Reaction

1-Day -1.58%

5-Day -0.4%

30-Day -3.31%

Key Takeaways

Q4 revenue growth reached 6.5%, contributing to a full-year growth of 6.8%, led by Imaging and Varian segments.
Adjusted EPS exclusion of tariffs showed a 10% year-over-year increase, reflecting strong operational performance.
Proposed dividend increased to EUR 1 alongside improvements in free cash flow, reducing leverage to 2.8x EBITDA.
Book-to-bill ratio for equipment was at 1.12, indicating a healthy sales pipeline despite stagnant performance in China.
Diagnostics segment margin improvement continues, although revenue growth is subdued due to market challenges in China.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit SHL.DE on AllInvestView.

Next Q1 2026